Introducing Allday® 5000 Sensitive Toothpaste, the latest addition to Elevate Oral Care’s innovative line of prescription-strength toothpastes. Allday 5000 Sensitive does not contain SLS or CAPB. It uses the same next-generation glycolipid surfactant…
Read More...
Unlicensed Dental Providers Put Patients and the Profession at Risk
Reports of unlicensed individuals performing dental procedures are on the rise, leaving patients financially and physically harmed…
Precision Begins With Diagnosis
Accurate diagnosis is the cornerstone of predictable full-arch rehabilitation, especially in complex maxillary cases where anatomy,…
Real, Lasting Change Happens on the Patient’s Terms
True behavior change doesn’t happen because we tell patients what to do, but rather it happens when they discover their own reasons…
CMS Rule Cements the Importance of Oral and Systemic Health Integration
A new Centers for Medicare & Medicaid Services policy marks a major step toward integrating dentistry and medicine. By adding…
Weekly Popular
Personal Finance
More Top Stories
Federal Safety Standard Closes the Gap in Eyewear Protection
According to the United States Centers for Disease Control and Prevention, about 2,000 US workers sustain a job-related eye injury each day that requires medical treatment. This includes oral health professionals, who are subject to…
Will Telehealth Be the Answer to Rising Pandemic-Related Mental Health Issues?
According to a study in The Lancet, COVID-19 brought more than viral illness, lockdowns, and business disruptions, it also led to an increase in mental health problems. Researchers reported 76 million more cases of anxiety disorders and 53…
Presence of Gene Increases Risk of Severe COVID-19 Illness
One of the most significant unanswered questions of the global pandemic is why some people experience mild symptoms while others become seriously ill and even die. The answer may be in our genes. Researchers from the United Kingdom have…
Pfizer to Seek FDA Approval for Its COVID-19 Antiviral Medication
On the heels of the United Kingdom’s authorization of a competing medication by Merck, Pfizer announced that its own antiviral drug designed to treat COVID-19 shows promising results. According to the company’s clinical trial on 775 adults…
UK Approves Use of Antiviral Medication to Treat COVID-19
The United Kingdom (UK) has authorized the use of an antiviral medication, molnupiravir, to reduce the severity of illness associated with COVID-19. Manufactured by the American pharmaceutical company, Merck, molnupiravir has been shown to…
Is COVID-19 Switching From Pandemic to Endemic?
Many public health experts suggest that the COVID-19 pandemic will come to a close by the end of 2022, and while it will not disappear, the pandemic will mutate into an endemic disease. This change will mean that most people will have…
Pending Legislation Promotes Oral Health Literacy
Federal legislation of interest to the oral health community was recently included in a hearing held by the U.S. House of Representatives’ Energy and Commerce Committee: the Oral Health Literacy and Awareness Act of 2021 (H.R. 4555).…
The Demographics of COVID-19 Continue to Evolve
At the start of the COVID-19 pandemic, it was clear who was at greatest risk for COVID-19-related mortality and morbidity—older adults and those with preexisting conditions such as diabetes, and where—urban centers with dense populations in…
A Sad COVID-19 Milestone Reached: 5 Million People Dead
While the United States is experiencing a much-needed slow down in the number of new COVID-19 cases across the country, a tragic milestone has been met—throughout the globe, more than 5 million people have died due to illness caused by …
New Colgate® Optic White® Professional
New Colgate® Optic White® Professional is extraordinary whitening made simple. Help patients achieve a dramatically whiter smile in just 5 days, when used as directed. ALL-NEW patented technology designed for no tooth sensitivity, no gum…
Market Media
- Advertisement -
